Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies (SKINTARGET)

Gustave Roussy

Status: Unknown

Conditions: Cancer

Treatments: Procedure: Biopsy

Study type: Interventional

Funder types: Other

Identifiers

NCT02517281

2010/1664 (Other Identifier)

2010-A01052-37

Details and patient eligibility

About

The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.

Enrollment: 700 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with cancer beginning a targeted therapy
• Patients able to follow the protocol
• Age >/= 18 years old
• Signed inform consent

Exclusion criteria

• Patient unable to follow the protocol, having a non cooperative behavior or unable to come to follow up visits or unable to complete the study
• Pregnant or breastfeeding woman

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

700 participants in 1 patient group

Patients having received targeted therapies

Experimental group

Description:

Patients treated using targeted therapies

Treatment:

Procedure: Biopsy